Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationManesh R. Patel, Robert M. Califf, Günter Breithardt et al.|New England Journal of Medicine|2011Cited by 9.4k
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A.A. Fox, Robert M. Califf, Jonathan P. Piccini et al.|European Heart Journal|2011Cited by 614
Leukocyte recruitment and expression of chemokines following different forms of vascular injuryFrederick G.P. Welt, Campbell Rogers, Philip Seifert et al.|Vascular Medicine|2003Cited by 79
Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716Carl D. Richards, John F. Paolini|Acta Dermato Venereologica|2020Cited by 21